Emyria losses deepen as drug development takes centre stage by Steve Jones March 1, 2022April 29, 2024 Emyria saw sales revenue decline by a third in the first six months of the financial […]
Cann Group and Emyria go their separate ways on S3 registration by Martin Lane August 13, 2021April 26, 2024
Emyria granted TGA approval for medical grade, smartphone-enabled, monitoring software by Martin Lane May 13, 2021April 26, 2024
